Generics 4

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Bezafibrate manufacturers

4 products found

Filters

Filters

Filters , active

Country of origin : Taiwan

Clear all

4 products found

bezafibrate

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Taiwan
GMP approvals
PICS
Manufacturer #20576

Established in 1961, this Manufacturer is a CTD dossier owner and manufacturer based in Yunlin County, Taiwan. With over six decades of experience, it operates GMP-certified facilities compliant with PIC/S GMP standards, producing a diverse range of products including tablets, capsules, oral liquids, external liquids, and health foods. As a GMP manufacturer, it holds certifications such as the Accreditation Certificate of Foreign Drug Manufacturer approved by Japan's Ministry of Health, Labour and Welfare, and a valid CGMP certificate from the Philippines FDA, ensuring adherence to international quality standards. The Manufacturer's products are distributed across various countries and regions worldwide. Its commitment to excellence as a CTD dossier owner and manufacturer and GMP manufacturer solidifies its reputation in the global pharmaceutical market.​

 

Manufacturer usually replies in 6 days

bezafibrate

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Taiwan
GMP approvals
PICS
Manufacturer #20504

​Established in 1961, this Manufacturer is a CTD dossier owner and manufacturer based in Taichung City, Taiwan. It operates GMP-certified facilities producing a diverse range of products, including tablets, capsules, oral liquids, external liquids, and health foods. As a GMP manufacturer, it ensures adherence to international quality standards. The Manufacturer's products are distributed across various countries and regions worldwide. Its commitment to excellence as a CTD dossier owner and manufacturer and GMP manufacturer solidifies its reputation in the global pharmaceutical market.​

 

Manufacturer usually replies in 10 days

bezafibrate

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Taiwan
GMP approvals
PICS
Manufacturer #20598

This CTD dossier owner and manufacturer has a PIC/S GMP-certified pharmaceutical factory that has been approved by the TFDA. In recent years, with the rapid development of science and technology, the mutual penetration and promotion of various disciplines have greatly promoted the development of pharmaceuticals. New methods, new technologies, new equipment, new ingredients and new ingredients in modern drug manufacturing continue to emerge. The basic research has been deepened, applied research has been more perfect, and the development of pharmaceutical dosage forms has entered the era of new drug release systems from traditional dosage forms such as tablets, capsules, and injections. New products of various controlled and sustained-release dosage forms are on the market, and the research on targeted drug delivery preparations and pulse-controlled automatic drug delivery systems is developing rapidly.

Manufacturer usually replies in 18 days

Want to see all 4 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

BEZAFIBRATE Manufacturers and Suppliers

We have found 8 verified bezafibrate manufacturers and bezafibrate suppliers from our global list of sellers. The pharmaceutical drug is available for sale in different forms such as tablets, tablets, modified release (MR), tablets, sustained release (sr), tablets, delayed-release (dr) from manufacturers in various countries including Israel, Brazil, Canada, European Union, Japan, South Korea, Mexico.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of bezafibrate offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for bezafibrate manufacturers and bezafibrate suppliers that you are looking for. These also enable you to check the dossier status of bezafibrate, and the GMP approvals of the different variants of bezafibrate. Also, each manufacturer or supplier product description contains essential information about bezafibrate including clinical data, stability zones, countries where bezafibrate is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over bezafibrate offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that bezafibrate manufacturers have, we qualify their companies before they are on-boarded on the platform. This allows us to screen bezafibrate manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible